158 related articles for article (PubMed ID: 36881459)
1. Considerations for application of benchmark dose modeling in radiation research: workshop highlights.
Chauhan V; Yu J; Vuong N; Haber LT; Williams A; Auerbach SS; Beaton D; Wang Y; Stainforth R; Wilkins RC; Azzam EI; Richardson RB; Khan MGM; Jadhav A; Burtt JJ; Leblanc J; Randhawa K; Tollefsen KE; Yauk CL
Int J Radiat Biol; 2023; 99(9):1320-1331. PubMed ID: 36881459
[TBL] [Abstract][Full Text] [Related]
2. Benchmark dose modeling of transcriptional data: a systematic approach to identify best practices for study designs used in radiation research.
Stainforth R; Vuong N; Adam N; Kuo B; Wilkins RC; Yauk C; Beheshti A; Chauhan V
Int J Radiat Biol; 2022; 98(12):1832-1844. PubMed ID: 35939275
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of transcriptomic datasets using benchmark dose modeling shows value in supporting radiation risk assessment.
Chauhan V; Adam N; Kuo B; Williams A; Yauk CL; Wilkins R; Stainforth R
Int J Radiat Biol; 2021; 97(1):31-49. PubMed ID: 32687419
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional benchmark dose modeling: Exploring how advances in chemical risk assessment may be applied to the radiation field.
Chauhan V; Kuo B; McNamee JP; Wilkins RC; Yauk CL
Environ Mol Mutagen; 2016 Oct; 57(8):589-604. PubMed ID: 27601323
[TBL] [Abstract][Full Text] [Related]
5. BMDExpress Data Viewer - a visualization tool to analyze BMDExpress datasets.
Kuo B; Francina Webster A; Thomas RS; Yauk CL
J Appl Toxicol; 2016 Aug; 36(8):1048-59. PubMed ID: 26671443
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the influences of confounding variables on benchmark dose using a case study in the field of ionizing radiation.
Adam N; Vuong NQ; Adams H; Kuo B; Beheshti A; Yauk C; Wilkins R; Chauhan V
Int J Radiat Biol; 2022; 98(12):1845-1855. PubMed ID: 35939396
[TBL] [Abstract][Full Text] [Related]
7. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
Filipsson AF; Sand S; Nilsson J; Victorin K
Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
[TBL] [Abstract][Full Text] [Related]
8. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
[TBL] [Abstract][Full Text] [Related]
9. Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes.
Labib S; Williams A; Yauk CL; Nikota JK; Wallin H; Vogel U; Halappanavar S
Part Fibre Toxicol; 2016 Mar; 13():15. PubMed ID: 26979667
[TBL] [Abstract][Full Text] [Related]
10. A Web-Based System for Bayesian Benchmark Dose Estimation.
Shao K; Shapiro AJ
Environ Health Perspect; 2018 Jan; 126(1):017002. PubMed ID: 29329100
[TBL] [Abstract][Full Text] [Related]
11. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
12. A computational system for Bayesian benchmark dose estimation of genomic data in BBMD.
Ji C; Weissmann A; Shao K
Environ Int; 2022 Mar; 161():107135. PubMed ID: 35151117
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings.
Izadi H; Grundy JE; Bose R
Risk Anal; 2012 May; 32(5):830-5. PubMed ID: 22126138
[TBL] [Abstract][Full Text] [Related]
14. Application of benchmark dose modeling to protein expression data in the development and analysis of mode of action/adverse outcome pathways for testicular toxicity.
Chepelev NL; Meek ME; Yauk CL
J Appl Toxicol; 2014 Nov; 34(11):1115-21. PubMed ID: 25244189
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of subchronic toxicity data using the benchmark dose approach.
Gephart LA; Salminen WF; Nicolich MJ; Pelekis M
Regul Toxicol Pharmacol; 2001 Feb; 33(1):37-59. PubMed ID: 11259178
[TBL] [Abstract][Full Text] [Related]
16. Multiomics Point of Departure (moPOD) Modeling Supports an Adverse Outcome Pathway Network for Ionizing Radiation.
Song Y; Zheng K; Brede DA; Gomes T; Xie L; Kassaye Y; Salbu B; Tollefsen KE
Environ Sci Technol; 2023 Feb; 57(8):3198-3205. PubMed ID: 36799527
[TBL] [Abstract][Full Text] [Related]
17. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.
Davis JA; Gift JS; Zhao QJ
Toxicol Appl Pharmacol; 2011 Jul; 254(2):181-91. PubMed ID: 21034758
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
Gaylor DW; Aylward LL
Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
[TBL] [Abstract][Full Text] [Related]
19. Empirical analysis of BMD metrics in genetic toxicology part II: in vivo potency comparisons to promote reductions in the use of experimental animals for genetic toxicity assessment.
Wills JW; Long AS; Johnson GE; Bemis JC; Dertinger SD; Slob W; White PA
Mutagenesis; 2016 May; 31(3):265-75. PubMed ID: 26984301
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics Simultaneously Derives Benchmark Dose Estimates and Discovers Metabolic Biotransformations in a Rat Bioassay.
Sostare E; Bowen TJ; Lawson TN; Freier A; Li X; Lloyd GR; Najdekr L; Jankevics A; Smith T; Varshavi D; Ludwig C; Colbourne JK; Weber RJM; Crizer DM; Auerbach SS; Bucher JR; Viant MR
Chem Res Toxicol; 2024 Jun; 37(6):923-934. PubMed ID: 38842447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
